Malignant hypertension : A bright future
Copyright © 2019 Elsevier Masson SAS. All rights reserved..
Malignant hypertension has not disappeared, it has been forgotten. Its incidence is increasing again. It considerably worsens the prognosis of young patients (35 to 55 years old on average). There might be susceptibility factors, several hypotheses are under study. New diagnostic criteria and therapeutic options have been proposed and will have to be validated. Faced with these important challenges for patients, the first prospective multicentric register on this pathology will be set up in France in September 2019.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Presse medicale (Paris, France : 1983) - 48(2019), 12 vom: 24. Dez., Seite 1439-1444 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
L’hypertension artérielle maligne , un futur prometteur |
|---|
| Beteiligte Personen: |
Boulestreau, Romain [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 25.12.2019 Date Revised 25.12.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.lpm.2019.07.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM300803958 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM300803958 | ||
| 003 | DE-627 | ||
| 005 | 20231225103317.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.lpm.2019.07.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1002.xml |
| 035 | |a (DE-627)NLM300803958 | ||
| 035 | |a (NLM)31471092 | ||
| 035 | |a (PII)S0755-4982(19)30294-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Boulestreau, Romain |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Malignant hypertension |b A bright future |
| 246 | 3 | 3 | |a L’hypertension artérielle maligne , un futur prometteur |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.12.2019 | ||
| 500 | |a Date Revised 25.12.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Malignant hypertension has not disappeared, it has been forgotten. Its incidence is increasing again. It considerably worsens the prognosis of young patients (35 to 55 years old on average). There might be susceptibility factors, several hypotheses are under study. New diagnostic criteria and therapeutic options have been proposed and will have to be validated. Faced with these important challenges for patients, the first prospective multicentric register on this pathology will be set up in France in September 2019 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Cremer, Antoine |e verfasserin |4 aut | |
| 700 | 1 | |a Lorthioir, Aurélien |e verfasserin |4 aut | |
| 700 | 1 | |a Rubin, Sebastien |e verfasserin |4 aut | |
| 700 | 1 | |a Tharaux, Pierre Louis |e verfasserin |4 aut | |
| 700 | 1 | |a Persu, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Halimi, Jean Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Gosse, Philippe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Presse medicale (Paris, France : 1983) |d 1986 |g 48(2019), 12 vom: 24. Dez., Seite 1439-1444 |w (DE-627)NLM012618160 |x 2213-0276 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2019 |g number:12 |g day:24 |g month:12 |g pages:1439-1444 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lpm.2019.07.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2019 |e 12 |b 24 |c 12 |h 1439-1444 | ||